Archive for September 2022
Viewpoint: Identify the main inflection points in a business life cycle
What are the inflection points for your business? Drawing on client insights and perspectives, we have identified a few key moments in time. Read More
Read MoreTwo new Cambridge museums to tell stories of discovery
Two Cambridge institutions, the Broad Institute and MIT, are opening museums across the street from each other in Kendall Square in October to tell their stories of innovation to the public. Read More
Read MoreBoston Blockchain Week will be in-person this year. Here’s what to expect.
"There’s something for everyone here. And it’s not meant to be scary," said Ian Cain, co-founder and executive chair of Qubic Labs, the main organizer of the event. Read More
Read MoreForm D Friday: Raytheon alum gets $2.7M for infrastructure startup
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More
Read MoreFort Point lab conversion fails to win BPDA approval, at least for now
The vote marks a notable defeat — even if potentially only a temporary one — for lab developers appearing before the agency’s board. Read More
Read MoreThe railroad strike may be averted, but here’s how to defend against future supply chain disruptions
A tentative agreement may have averted a major railroad strike that would have wreaked havoc on supply chains, but supply chain disruptions aren’t going away. Here’s how to prepare. Read More
Read MorePrivate equity firm will take State Street’s place atop downtown tower
HarbourVest Partners has signed one of the biggest leases in Boston since the pandemic started. Read More
Read MoreFallon sues local manufacturer after N95 mask venture goes south
Joe Fallon’s company is accusing a West Bridgewater manufacturer of badly mismanaging the business and moving forward to sell the masks on its own. Read More
Read MoreThird Harmonic Bio bolsters fall IPO hopes with $185M debut
A Cambridge biotech, the first to go public in months, has hit the Nasdaq in a $185 million IPO in what industry watchers are hoping is an encouraging sign that the life sciences markets are beginning to stabilize. Read More
Read MoreAfter reported mail bomb, comfort dogs soothe Northeastern students
Around two dozen comfort dogs from nearby colleges and communities showed up outside the student center at Northeastern University on Thursday morning. Read More
Read More